|
|
|
|
|
|
|
|
|
|
|
|
| Webinar: Streamlining Vaccine Purification: Techniques for Modern Modalities | Advances in vaccine development demand faster, more efficient processes. This Thermo Fisher Scientific webinar explores chromatography purification tools that accelerate downstream development for diverse vaccine modalities, including mRNA, viral vectors, recombinant proteins, and VLPs. Through case studies on HPV, Malaria, and COVID-19, attendees will learn how affinity and ion exchange resins enable high-purity, high-yield purification from lab to large-scale production. Click here to learn more. |
|
|
FOCUS ON DOWNSTREAM MANUFACTURING |
|
|
|
By Irwin Hirsh, Q-Specialists AB | CPV can strengthen the bridge between compliance and continuous improvement. In this scenario, a hypothetical lab sets out to improve process yields and efficiency. | |
|
|
|
| Bridging Anti-E. coli HCP Antibodies And E. coli Antigens | Application Note | By Jared Isaac, Bryan Lanning, Jacob Stubbs, Alla Zilberman, and Eric Bishop, Cygnus Technologies Inc. | Read this expert comparative coverage analysis study performed to assess the reactivity of anti-E. coli HCP antibodies that support ELISA kits. |
|
|
| Demand More From Your Oligo Synthesizer | Article | Cytiva | The market for oligonucleotide therapeutics is expanding, and the pipeline is diverse. Gain insight into how you can fast-track your molecule's development with verified synthesizers, columns, and scientific support and expertise. |
|
|
| Optimize mAb Purification Using Protein A Membrane Chromatography | Poster | By M. Marinova, A.C. Lyons, M. DeVore, S. Madasu, M.C. Kerzic, and C.A. Mitchell, W.L. Gore & Associates | Discover how high throughput (HTP) screening can utilize membrane chromatography at comparable consumables costs to traditional resins without compromising CQAs for prescribed therapeutics. |
|
|
| Scalable Process Solution For EV Purification With 10X Yield Improvements | Poster | By Stephen Lenzini, Ph.D., Jae Jung, Madeline Cramer, Ph.D., Elie Zakhem, Ph.D., and Jon Rowley, Ph.D., RoosterBio | Biological components in conditioned media are a consistent problem during downstream processing of EVs. A novel in-process reagent prevents these issues and improves particle recovery 10-fold while maintaining CQAs. |
|
|
|
|
|
| Webinar: Filtration unfiltered: Technology to meet new bioprocessing challenges | Join Cytiva experts as they reveal how to overcome filtration challenges in today’s evolving biopharma landscape. Discover how process intensification drives efficiency, explore strategies for managing diverse drug modalities, and gain insights into key regulatory considerations—including PUPSIT and PFAS. Don’t miss this opportunity to learn how smarter filtration solutions can boost productivity and support sustainable bioprocessing. Click here to learn more. |
|
|
DOWNSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
